# Efficacy and Safety of Phototherapy in the Treatment of Loss of Smell Post Acute Infection of Coronavirus 19

> **NCT05177445** · NA · UNKNOWN · sponsor: **Respiralab** · enrollment: 40 (estimated)

## Conditions studied

- Smell Disorders

## Interventions

- **COMBINATION_PRODUCT:** Phototherapy
- **COMBINATION_PRODUCT:** OT+Corticosteroids

## Key facts

- **NCT ID:** NCT05177445
- **Lead sponsor:** Respiralab
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04
- **Primary completion:** 2022-12
- **Final completion:** 2023-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05177445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05177445, "Efficacy and Safety of Phototherapy in the Treatment of Loss of Smell Post Acute Infection of Coronavirus 19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05177445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*